MAPT and Alzheimer disease: The diversity and multiple strains of tau, which are also broadly divided into AD-tau and non-AD-tau, make finding tau ligands challenging (Choi et al., 2018; Schöll et al., 2019; Buchholz and Zempel, 2024).